EPISODE · Apr 24, 2026 · 7 MIN
SHTG Digest — Friday April 24, 2026
from SHTG Daily Digest — Weiss Lab
The week's literature is dominated by meta-analytic syntheses of APOC3-targeting agents (olezarsen and plozasiran) and ANGPTL3 inhibitors, converging on a consistent message — both pathways produce profound TG lowering with acceptable safety profiles, and plozasiran in particular now has the first prospective RCT evidence for reducing recurrent acute pancreatitis in FCS patients.
Embed this episode
NOW PLAYING
SHTG Digest — Friday April 24, 2026
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.